Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSummit Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2025 | 6 | -$0.07 | -$0.06 | -$0.07 |
| Q3 2025 | 8 | -$0.19 | -$0.08 | -$0.13 |
| Q4 2025 | 8 | -$0.28 | -$0.12 | -$0.19 |
| Q1 2026 | 4 | -$0.27 | -$0.09 | -$0.21 |
| Q2 2026 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q3 2026 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q4 2026 | 1 | -$0.25 | -$0.25 | -$0.25 |
Summit Therapeutics Inc. Earnings Date And Information
Summit Therapeutics Inc. last posted its earnings results on Monday, August 11th, 2025. The company reported $-0.76 earnings per share for the quarter, missing analysts' consensus estimates of $-0.09081 by $0.66919. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Summit Therapeutics Inc. has generated $0 earnings per share over the last year ($-0.31 diluted earnings per share) and currently has a price-to-earnings ratio of -15.17. Summit Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 23rd, 2026 based on prior year's report dates.
Summit Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/11/2025 | Q3 2025 | -$0.09 | -$0.31 | -0.22 | $42.31 M | $0 |
| 08/11/2025 | Q2 2025 | -$0.09 | -$0.76 | -0.67 | $0 | $0 |
| 05/01/2025 | Q1 2025 | -$0.09 | -$0.09 | 0.01 | $0 | $0 |
| 02/24/2025 | Q4 2024 | -$0.08 | -$0.08 | -0 | $0 | $0 |
| 10/30/2024 | Q3 2024 | -$0.07 | -$0.08 | -0.01 | $0 | $0 |
| 08/06/2024 | Q2 2024 | -$0.06 | -$0.09 | -0.03 | $0 | $0 |
| 05/01/2024 | Q1 2024 | -$0.06 | -$0.06 | -0 | N/A | $0 |
| 02/20/2024 | Q4 2023 | N/A | -$0.05 | N/A | N/A | $0 |
| 11/07/2023 | Q3 2023 | N/A | -$0.03 | N/A | N/A | $0 |
| 08/09/2023 | Q2 2023 | N/A | -$0.02 | N/A | N/A | $235.00 K |
| 05/11/2023 | Q1 2023 | N/A | -$1.43 | N/A | N/A | $0 |
| 03/09/2023 | Q4 2022 | -$0.26 | -$0.08 | 0.18 | N/A | $705 |
| 11/09/2022 | Q3 2022 | -$0.26 | -$0.10 | 0.16 | N/A | $220.00 K |
| 08/11/2022 | Q2 2022 | -$0.27 | -$0.12 | 0.15 | N/A | $235.00 K |
| 05/11/2022 | Q1 2022 | -$0.28 | -$0.15 | 0.13 | N/A | $250.00 K |
| 03/17/2022 | Q4 2021 | -$0.27 | -$0.28 | -0.01 | N/A | $251.00 K |
| 11/15/2021 | Q3 2021 | -$0.29 | -$0.20 | 0.09 | N/A | $1.31 M |
| 08/12/2021 | Q2 2021 | N/A | -$0.27 | N/A | $3.22 M | $57.00 K |
| 05/17/2021 | Q1 2021 | N/A | -$0.21 | N/A | $3.19 M | $192.00 K |
| 03/31/2021 | Q4 2020 | N/A | -$0.18 | N/A | $2.90 M | $185.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Summit Therapeutics Inc. Earnings: FAQ's
Summit Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 23rd, 2026 based offlast year's report dates.
The conference call for Summit Therapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Summit Therapeutics Inc.'s latest earnings report can be read online.
Summit Therapeutics Inc. (:SMMT) has a recorded net income of $-221,315,000.Summit Therapeutics Inc. has generated $-0.31 earnings per share over the last four quarters.
Summit Therapeutics Inc. (:SMMT) has a price-to-earnings ratio of -15.17 and price/earnings-to-growth ratio is 0.67.